A CROWD of reporters and Hollywood types, drawn by the drama and glamour of the event, are likely to jostle to find a seat in a courtroom in San Jose on August 31st for what may be the next, perilous act for a woman once touted as the next Steve Jobs and the world’s youngest self-made female billionaire. Jury selection will begin for the fraud trial of Elizabeth Holmes, the former chief executive of Theranos, a startup which attempted to revolutionise the process of blood testing but failed spectacularly in 2016 after the press and regulators probed the company’s inflated claims.
These sorts of cases usually hinge on subtle
→ Continue reading at The Economist
